Abbott Laboratories (ABT) has an average rating of overweight and mean price target of $115.74, according to analysts polled by FactSet.
What else is happening in Research?
Research
Update: BofA Downgrades Fox Factory to Underperform From Neutral, Cuts Price Target to $20 From $24
(Updated to include BofA's commentary)BofA Securities downgraded Fox Factory (FOXF) to underperform from neutral and lowered its price target to $20 from $24.While the company's progress through its Profit Optimization Initiative, centered on business line rationalization, supply chain and materials cost productivity, and opex reduction, are expected to drive an uptick in H2 margins, the brokerage sees limited 2026 earnings upside.Fox Factory has an average rating of overweight and mean price target of $21.67, according to analysts polled by FactSet.Price: $16.88, Change: $-1.22, Percent Change: -6.72%
$FOXF
Research
BofA Securities Downgrades Scorpio Tankers to Underperform From Buy, Price Target is $78
Scorpio Tankers (STNG) has an average rating of buy and mean price target of $98.67, according to analysts polled by FactSet.Price: $68.87, Change: $-1.27, Percent Change: -1.80%
$STNG
Research
CITIC Securities Initiates IBM at Buy With $294 Price Target
IBM (IBM) has an average rating of overweight and mean price target of $298.53, according to analysts polled by FactSet.
$IBM